Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Canara Robeco Large Cap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹101.07 |
| 12 Apr 2015 | ₹154.29 |
| 31 May 2016 | ₹145.46 |
| 19 Jul 2017 | ₹182.26 |
| 07 Sep 2018 | ₹213.70 |
| 27 Oct 2019 | ₹210.31 |
| 15 Dec 2020 | ₹244.39 |
| 03 Feb 2022 | ₹311.14 |
| 25 Mar 2023 | ₹297.28 |
| 12 May 2024 | ₹408.99 |
| 01 Jul 2025 | ₹468.73 |
| 20 Aug 2026 | ₹440.02 |
| Metric | Canara Robeco · Direct · IDCW NAV ₹53.33 Very High risk ★★★☆☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| -5.24% | -3.12% | |
| +8.84% | +9.35% | |
| +7.71% | +8.00% | |
| +10.76% | +7.97% | |
| +11.48% | +9.16% | |
| +6.91% | — | |
| +12.66% | +10.38% | |
| +12.59% | +9.26% | |
| +12.56% | +8.80% | |
| Risk | ||
| 13.58% | 14.48% | |
| 0.17 | 0.16 | |
| 0.23 | 0.21 | |
| -33.89% | -36.60% | |
| Nifty 100 | — | |
| -0.91% | +0.11% | |
| 0.97 | 0.98 | |
| 102.6% | 96.8% | |
| 111.5% | 98.3% | |
| 0.61% | 1.08% | |
| ₹16,459Cr | ₹1,495Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 16% | 58% | |
| Shridatta Bhandwaldar · 5.2y | — | |
| 02 Jan 2013 | — | |
| 60 | — | |
| 48.1% | — | |
| 2.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.